Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats

Neurosurgery

Volumn 62, Issue 1, 2008, Pages 232-240

  Hishikawa, Tomohito ^a,b   Ono, Shigeki ^a   Ogawa, Tomoyuki ^a   Tokunaga, Koji ^a   Sugiu, Kenji ^a   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Brainstem; Cerebral vasospasm; Deferoxamine; Hypoxia inducible factor 1; Rats; Subarachnoid hemorrhage

Indexed keywords

BRAIN PROTEIN; DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN STEM; BRAIN VASOSPASM; CONTROLLED STUDY; CORRELATION ANALYSIS; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; ANIMAL; BRAIN CIRCULATION; DISEASE MODEL; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN STEM; CEREBROVASCULAR CIRCULATION; DEFEROXAMINE; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 41749119704     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000311082.88766.33     Document Type: Article

References (42)

1. Andrews P, Papadakis N, Gavras H: Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition. Stroke 13:480-483, 1982.
2. Arthur AS, Fergus AH, Lanzino G, Mathys J, Kassell NF, Lee KS: Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Neurosurgery 41:1385-1392, 1997.
3. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR: Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48:285-296, 2000.
4. Chavez JC, LaManna JC: Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1. J Neurosci 22:8922-8931, 2002.
5. Delgado TJ, Brismar J, Svendgaard NA: Subarachnoid hemorrhage in the rats: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16:595-602, 1985.
6. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De Vico G, Piedimonte G, Salpietro FM, Tomasello F: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 99:5627-5631, 2002.
7. Harada T, Mayberg MR: Inhibition of delayed arterial narrowing by the ironchelating agent deferoxamine. J Neurosurg 77:763-767, 1992.
8. Horky LL, Pluta RM, Boock RJ, Oldfield EH: Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 88:298-303, 1998.
9. Hua Y, Keep RF, Hoff JT, Xi G: Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab 23:1448-1454, 2003.
10. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT: Brain edema after experimental intracerebral hemorrhage: Role of hemoglobin degradation products. J Neurosurg 96:287-293, 2002.
11. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr: HIF? targeted for VHL-mediated destruction by proline hydroxylation: Implication for O2 sensing. Science 292:464-468, 2001.
12. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim Av, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIF-1? to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472, 2001.
13. Jackowski A, Crockard A, Burnstock G, Russell RR, Kristek F: The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat. J Cereb Blood Flow Metab 10:835-849, 1990.
14. Jiang Y, Wu J, Keep RF, Hua Y, Hoff JT, Xi G: Hypoxia-inducible factor-1? accumulation in the brain after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 22:689-696, 2002.
15. Jin KL, Mao XO, Nagayama T, Goldsmith PC, Greenberg DA: Induction of vascular endothelial growth factor and hypoxia-inducible factor-1α by global ischemia in rat brain. Neuroscience 99:577-585, 2000.
16. Jośko J: Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res 981:58-69, 2003.
17. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990.
18. Luo Z, Harada T, London S, Gajdusek C, Mayberg MR: Antioxidant and iron-chelating agents in cerebral vasospasm. Neurosurgery 37:1154-1159, 1995.
19. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275, 1999.
20. Meguro T, Clower BR, Carpenter R, Parent AD, Zhang JH: Improved rat model for cerebral vasospasm studies. Neurol Res 23:761-766, 2001.
21. Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T: Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 32:636-642, 2001.
22. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G: Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100:672-678, 2004.
23. Naveri L, Stromberg C, Saavedra JM: Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 14:1096-1099, 1994.
24. Ono S, Komuro T, Macdonald RL: Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 96:1094-1102, 2002.
25. Ostrowski RP, Colohan AR, Zhang JH: Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 25:554-571, 2005.
26. Palmer C, Roberts RL, Bero C: Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25:1039-1045, 1994.
27. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, Scharff A, Dirnagl U, Meisel A: Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22:520-525, 2002.
28. Prass K, Scharff A, Ruscher K, Löwl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34:1981-1986, 2003.
29. Pugh CW, Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677-684, 2003.
30. Ramírez-Bergeron DL, Simon MC: Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 19:279-286, 2001.
31. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 275:26765-26771, 2000.
32. Semenza GL: Hypoxia-inducible factor 1: Control of oxygen homeostasis in health and disease. Pediatr Res 49:614-617, 2001.
33. Semenza GL: Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64:993-998, 2002.
34. Semenza GL: Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106:809-812, 2000.
35. Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, Sun H, Waga S, Tanaka T: Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 104:59-66, 1999.
36. Tsurutani H, Ohkuma H, Suzuki S: Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Stroke 34:1497-1500, 2003.
37. Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Raabe A, Preibisch C, Zanella FE, Seifert V: Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: Clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 58:1190-1197, 2006.
38. Vollmer DG, Hongo K, Ogawa H, Tsukahara T, Kassell NF: A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28:27-32, 1991.
39. Wang GL, Semenza GL: Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 82:3610-3615, 1993.
40. White BC, Krause GS, Aust SD, Eyster GE: Postischemic tissue injury by iron-mediated free radical lipid peroxidation. Ann Emerg Med 14:804-809, 1985.
41. waf1/cip1, and erythropoietin. J Neurosci 19:9821-9830, 1999.
42. Zhang Z, Nagata I, Kikuchi H, Xue JH, Sakai N, Sakai H, Yanamoto H: Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: Vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. Stroke 32:1665-1672, 2001.